NIFTY
-11.35  -0.10%
 11521.05
S&P BSE SENSEX
23.28  0.06%
 38386.75
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 20-Mar-2019
NSE
0.75    0.22%
Rs. 337.90
 
Days Low
Rs. 336.2
Days High
Rs. 341.7

Open Rs. 338
 
52 week Low
Rs. 306.35
52 week High
Rs.432.4
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.338.00
1.45    0.43%
on 20-Mar-2019
BSE
1.45    0.43%
Rs. 338.00
 
Days Low
Rs. 336.25
Days High
Rs. 341.9

Open Rs. 337.5
 
52 week Low
Rs. 305.95
52 week High
Rs.432.5
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.337.90
0.75    0.22%
 
 
Last Price (Rs.)  338.00 Value  9131873.00
Net Change (Rs.)  1.45 Best Buy  0.00
Volume  26945 Best Sell  0.00
Prev.Close (Rs.)  336.55 Best Quantity  0
Open (Rs.)  338.00 Sell Quantity  0
High (Rs.)  341.70 52-Week High (Rs.)  432.40
Low (Rs.)  336.20 52-Week Low (Rs.)  306.35
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  346025.00
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments0.00 0.00 1009.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 474.35 1138125 77.46 0.00 0.42
Piramal Enterprises 2612.25 481816 1083.86 90.82 0.96
Dr. Reddys Lab 2747.25 456225 749.81 80.45 0.73
Aurobindo Pharma 777.25 455397 188.62 25.12 0.32
Divis Lab 1677.55 445337 251.75 51.21 0.60
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2018Sep 2018Jun 2018
Net Sales16755.0016445.0015049.00
Operating Profit5058.009191.004896.00
PBDT5213.008786.004516.00
Net Profit3633.006665.003102.00
More> 
 
Company News
3/20/2019 12:00:00 AM
Cadila Healthcare trades in green on the BSE
3/19/2019 12:00:00 AM
Zydus Cadila receives final approval from USFDA for Acyclovir Ointment
3/19/2019 12:00:00 AM
Cadila Healthcare informs about press release
More>
 
Ratios
   Earnings Per Share (Rs)10.65 
   Book NAV/Share(Rs)75.64 
   PAT Margin (%)18.73 
   Asset Turnover(x)0.46 
   PER(x)35.55 
   Yield(%)0.92 
   EV/Core EBITDA(x)22.36 
   M Cap / Sales6.67 
   Net Sales Growth(%)79.83 
   PAT Growth(%)64.80 
   Total Debt/Equity(x)0.37 
   Current Ratio(x)1.25 
   Quick Ratio(x)0.82 
   Total Debt/Mcap(x)0.07 
More>